RecruitingNCT05495776
Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
Sponsor
State Scientific Centre of Coloproctology, Russian Federation
Enrollment
2,500 participants
Start Date
Aug 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at how common Lynch syndrome is among patients with colorectal cancer. Lynch syndrome is an inherited condition that increases the risk of colon and other cancers. By screening newly diagnosed colon cancer patients, researchers aim to identify patients who may have this hereditary condition and could benefit from genetic counseling.
**You may be eligible if...**
- You are 18 or older with a confirmed diagnosis of colon adenocarcinoma (colon cancer)
- You have not yet started cancer treatment (or it has been over 12 months since treatment for a previous cancer)
- You are able to follow the study requirements according to your doctor
- You are willing to give written informed consent
**You may NOT be eligible if...**
- You are currently receiving chemotherapy or radiation for colon cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05495776
Related Trials
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
NCT073375906 locations
A Study of a Urine Test to Detect Colorectal Cancer
NCT076490574 locations
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
NCT0694844835 locations
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
NCT075785711 location
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT000018231 location